Article
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer
2023-02-08
Abstract excerpt
Brachyury is a transcription factor belonging to the T-box gene family and is involved in the posterior formation of the mesoderm and differentiation of chordates. As the overexpression of Brachyury is a poor prognostic factor in a variety of cancers, the establishment of Brachyury-targeted therapy would be beneficial for the treatment of aggressive tumors. Because transcription factors are difficult to treat with...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1be98980-13e4-5049-8c12-8efc6c4bddf3
- DOI
- 10.21203/rs.3.rs-2553923/v1
